Literature DB >> 1486690

Circulating lipids and minor abnormalities of thyroid function.

J V Parle1, J A Franklyn, K W Cross, S R Jones, M C Sheppard.   

Abstract

OBJECTIVE: We determined the effect of subclinical hyperthyroidism (defined as low circulating TSH with normal serum free T4) and subclinical hypothyroidism (raised serum TSH with normal free T4) on fasting levels of blood lipids.
DESIGN: Prospective study of lipid concentrations in patients identified as having abnormal TSH. PATIENTS: Patients were identified in a population screening study of those over 60 years, with persistently low TSH with normal free T4 (n = 27) or high TSH but normal free T4 (n = 57). Patients were matched to controls with normal serum TSH by age, sex and body mass index. MEASUREMENTS: Serum TSH, free T4, free T3, total cholesterol, low density lipoprotein (LDL) cholesterol and high density lipoprotein (HDL) cholesterol.
RESULTS: Serum free T4 measurements were significantly higher in those with subclinical hyperthyroidism than in their controls (P < 0.001) and lower in those with subclinical hypothyroidism than in matched controls (P < 0.001). Measurement of fasting lipids in patients and controls revealed a marked (12.2%) reduction in serum total cholesterol in subclinical hyperthyroidism (P < 0.01); no significant difference in fasting lipids between patients with subclinical hypothyroidism and controls was observed.
CONCLUSIONS: Differences in free T4 between those with low or high TSH and controls with normal TSH suggest that abnormalities of TSH directly reflect thyroid hormone excess and deficiency. A reduction in cholesterol in those with subclinical hyperthyroidism suggests a direct influence of thyroid hormone excess on lipid metabolism in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486690     DOI: 10.1111/j.1365-2265.1992.tb02351.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Subclinical hypothyroidism revisited. When is not enough really not enough?

Authors:  D R Goldmann
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

2.  The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.

Authors:  R Serter; B Demirbas; B Korukluoglu; C Culha; E Cakal; Y Aral
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  The relation of Graves' ophthalmopathy to circulating thyroid hormone status.

Authors:  J M Kim; L LaBree; L Levin; S E Feldon
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

Review 4.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

5.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18

Review 6.  Physiopathological aspects of the subclinical alterations of thyroid function associated with acute coronary syndromes.

Authors:  C S Stamate; A M Andronescu; A C Nechita; C Delcea; E M Mihu; M M Vintila
Journal:  J Med Life       Date:  2013-12-25

7.  Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study.

Authors:  Sara Kazempour-Ardebili; Atefeh Amouzegar; Maryam Tohidi; Atieh Amouzegar; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2021-03-17

8.  Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.

Authors:  Massimo Giusti; Lorenzo Mortara; Roberta Degrandi; Francesca Cecoli; Michele Mussap; Guido Rodriguez; Diego Ferone; Francesco Minuto
Journal:  Thyroid Res       Date:  2008-09-29

9.  Subclinical Hyperthyroidism: Status of the Cholesterol Transfers to HDL and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.

Authors:  Gilbert A Sigal; Thauany M Tavoni; Bruna M O Silva; Roberto Khalil-Filho; Lenine G Brandão; Edmund C Baracat; Raul C Maranhão
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-02       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.